Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-26 Purchase |
2021-04-27 4:03 pm |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
5,000 | $5 | $25,000 | 68,827 (Indirect Direct) |
View |
| 2021-04-26 Purchase |
2021-04-27 4:03 pm |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner |
12,000 | $5 | $60,000 | 1,298,344 (Indirect Direct) |
View |
| 2021-04-26 Purchase |
2021-04-27 4:02 pm |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
12,000 | $5 | $60,000 | 22,000 (Direct) |
View |
| 2021-04-26 Purchase |
2021-04-27 4:01 pm |
NeuBase Therapeutics Inc. | NBSE | Mann William Roland COO |
5,000 | $5 | $25,000 | 5,000 (Direct) |
View |
| 2020-06-09 Purchase |
2020-06-10 11:50 am |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner |
1,275 | $7.7339 | $9,861 | 2,560,164 (Indirect Direct) |
View |
| 2020-05-21 Purchase |
2020-05-26 4:39 pm |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner |
1,250 | $8.0888 | $10,111 | 2,558,889 (Indirect Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 3:25 pm |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A Lipizzaner LLC President and CEO 10% Owner |
10,000 | $6 | $60,000 | 2,557,639 (Indirect Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 2:18 pm |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
10,000 | $6 | $60,000 | 10,000 (Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 12:28 pm |
NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary |
1,000 | $6 | $6,000 | 11,630 (Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 09:56 am |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
10,833 | $6 | $64,998 | 63,827 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-29 Option Award |
2020-12-30 5:01 pm |
N/A 2030-12-29 |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner |
164,925 | $0 | 1,451,269 (Direct) |
View |
| 2020-11-23 Gift |
2020-12-30 5:01 pm |
N/A N/A |
NeuBase Therapeutics Inc. | NBSE | Stephan Dietrich A President and CEO 10% Owner |
6,369,097 | $0 | 1,451,269 (Indirect) |
View |
| 2020-12-29 Option Award |
2020-12-30 5:01 pm |
N/A 2030-12-29 |
NeuBase Therapeutics Inc. | NBSE | Backenroth Samuel CFO, Treasurer & Secretary |
41,915 | $0 | 41,915 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-02 09:46 am |
N/A 2030-12-01 |
NeuBase Therapeutics Inc. | NBSE | Bradshaw Curt Chief Scientific Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:20 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
14,634 | $0 | 14,634 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:20 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | Miralles Gines Diego Director |
14,634 | $0 | 14,634 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:20 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | RICHMAN ERIC I Director |
14,634 | $0 | 14,634 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:19 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | PRENDERGAST FRANKLYN G Director |
14,634 | $0 | 14,634 (Direct) |
View |
| 2020-07-27 Option Award |
2020-07-28 4:22 pm |
N/A 2030-07-27 |
NeuBase Therapeutics Inc. | NBSE | Mann William Roland COO |
175,000 | $0 | 175,000 (Direct) |
View |